Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells
- 15 November 2004
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 60 (4) , 1220-1232
- https://doi.org/10.1016/j.ijrobp.2004.07.689
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiationInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Interaction of pemetrexed disodium (ALIMTA, multitargeted antifolate) and irradiation in vitroInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Head and Neck CancerNew England Journal of Medicine, 2001
- Pemetrexed Disodium: A Novel Antifolate Clinically Active Against Multiple Solid TumorsThe Oncologist, 2001
- Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiationInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Carcinoma of the Anal CanalNew England Journal of Medicine, 2000
- Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agentsInvestigational New Drugs, 1997
- Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor.Proceedings of the National Academy of Sciences, 1996
- Potentiation of cytotoxic cancer therapies by TNP‐470 alone and with other anti‐angiogenic agentsInternational Journal of Cancer, 1994
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971